From: Increased augmentation index in patients with Ehlers-Danlos syndrome
 | EDS cohort (n = 61) | Healthy control cohort (n = 61) | p-value |
---|---|---|---|
Sex (f / m) | 43 / 18 | 43 / 18 | – |
Caucasian, % | 100 | 100 | – |
Age, years | 39.3 ± 14.6 | 35.6 ± 11.4 | 0.13 |
Height, cm | 168.5 (161.0/174.5) | 169.0 (162.5/176.5) | 0.47 |
Weight, cm | 65.0 (54.0/76.0) | 65.0 (58.0/75.5) | 0.73 |
BMI, kg/m2 | 22.7 (20.4/25.9) | 22.9 (20.8/24.7) | 0.96 |
BSA, m2 | 1.3 (1.1/1.5) | 1.3 (1.2/1.5) | 0.81 |
Neck, cm | 33 (31/37) | 33 (32/37) | 0.70 |
Waist, cm | 73 (67/85) | 76 (69.0/81.0) | 0.87 |
Blood pressure systolic (office), mmHg | 117.4 ± 14.2 | 112.8 ± 12.8 | 0.07 |
Blood pressure diastolic (office), mmHg | 80.6 ± 10.8 | 76.1 ± 11.8 | 0.03 |
Pulse, min−1 | 76.7 (67/84.7) | 69.0 (64.0/76.7) | 0.025 |
Alcohol units per week, units | 0 (0/1) | 0 (0/2) | 0.74 |
Current Smoker, n (%) | 15 (25%) | 9 (15%) | 0.20 |
Diabetes, n (%) | 3 (4.9%) | 0 (0%) | 0.08 |
Arterial hypertension, n (%) | 10 (16%) | 1 (2%) | 0.004 |
Pack years of smoking, n | 0 (0/3) | 0 (0/1) | 0.11 |
Antihypertensive drugs, n (%) | 10 (16%) | 1 (2%) | 0.004 |
NSAIDs, n (%) | 13 (21%) | 2 (3%) | 0.002 |
Lipid lowering drugs, n (%) | 0 | 0 | – |
Antiplatelet drugs, n (%) | 1 (1.64%) | 0 | 0.32 |
Antidiabetic drugs, n (%) | 0 | 0 | – |